Thomas W MacAllister

Title: Thomas W MacAllister: Innovator in Therapeutic Enzymes

Introduction

Thomas W MacAllister is a notable inventor based in Columbia, SC (US). He has made significant contributions to the field of therapeutic enzymes, holding 2 patents that focus on innovative methods for producing glutaminase. His work has implications for both antiviral and anticancer therapies.

Latest Patents

MacAllister's latest patents include a method for producing therapeutically suitable glutaminase. This invention involves the molecular cloning of DNA encoding a glutaminase that is free of contaminating endotoxin. The resulting polypeptide has been identified as a potent anti-viral agent. When coupled with an anti-tumor monoclonal antibody, it serves as a powerful anticancer agent. This glutaminase is particularly effective in treating lung, breast, and colon cancer cells, as well as HIV-infected cells. Another patent focuses on genetically engineered glutaminase and its applications in antiviral and anticancer therapy, reiterating the importance of this enzyme in modern medicine.

Career Highlights

Throughout his career, MacAllister has worked with various companies, including Me Medical Enzymes AG. His expertise in the field of therapeutic enzymes has positioned him as a key figure in the development of innovative treatments.

Collaborations

MacAllister has collaborated with notable professionals in his field, including Joseph W Roberts and Natarajan Sethuraman. These collaborations have further enhanced his research and contributions to therapeutic enzyme development.

Conclusion

Thomas W MacAllister's work in the field of therapeutic enzymes has paved the way for advancements in antiviral and anticancer therapies. His innovative patents and collaborations highlight his significant impact on medical research and treatment options.